Cerebral Aneurysm Epidemiology Forecast 2026-2035

A cerebral aneurysm is a focal dilation of a cerebral artery that poses a risk of rupture and subarachnoid hemorrhage, a serious neurological emergency. According to Andrew M. Jersey, et al., 2023, the global prevalence of cerebral aneurysms is estimated at approximately 3.2 % of the adult population, with many cases asymptomatic and undiagnosed, according to epidemiological studies. As per the cerebral aneurysm epidemiology forecast, this prevalence underlines substantial healthcare impact and growing demands for improved diagnosis and treatment.

Cerebral Aneurysm Epidemiology Forecast Report Coverage

The analyst's “Cerebral Aneurysm Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of cerebral aneurysm. It projects the future incidence and prevalence rates of cerebral aneurysm cases across various populations. The study covers age, gender, and type as major determinants of the cerebral aneurysm population. The report highlights patterns in the prevalence of cerebral aneurysm over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of cerebral aneurysm in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Cerebral Aneurysm Understanding: Disease Overview

Cerebral aneurysm is a cerebrovascular disorder characterized by a localized dilation or ballooning of a weakened arterial wall within the brain. It typically develops due to structural weakness in the vessel wall, hemodynamic stress, genetic predisposition, hypertension, or smoking. Most aneurysms occur in the arteries of the Circle of Willis. Cerebral aneurysms are broadly classified into saccular (berry) aneurysms, fusiform aneurysms, and dissecting aneurysms. While many remain asymptomatic, rupture can lead to subarachnoid hemorrhage, a life-threatening condition associated with significant morbidity and mortality.

Cerebral Aneurysm Epidemiology Perspective

The cerebral aneurysm epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the cerebral aneurysm epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for cerebral aneurysm and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Andrew M. Jersey et al., 2023, the global prevalence of cerebral aneurysms is approximately 3.2%, while East Bay Brain & Spine estimate a range of 3-5%, suggesting that nearly 1 in 50 adults may harbor an unruptured aneurysm without symptoms, as per Kalra Hospitals.
• As per East Bay Brain & Spine, cerebral aneurysms are most diagnosed in adults aged 40-60 years, with a mean age of 50 years reported by Andrew M. Jersey et al., 2023. Qannas et al., 2026, observed that women tend to experience ruptures at older ages.
• According to Andrew M. Jersey et al., 2023, the overall gender ratio is approximately 1:1; however, after 50 years, female predominance increases to nearly 2:1, likely due to hormonal changes. Qannas et al., 2026, reported 51.83% female and 48.17% male distribution.
• As per Andrew M. Jersey et al., 2023, the annual rupture incidence causing subarachnoid hemorrhage is approximately 10 per 100,000 population, with higher rupture rates reported in Finnish and Japanese populations despite similar baseline prevalence.
• According to East Bay Brain & Spine and Kalra Hospitals, mortality following aneurysmal subarachnoid hemorrhage ranges from 40-50%, with Andrew M. Jersey et al., 2023, further noting 20% early mortality and 30-40% long-term morbidity among survivors.

Country-wise Cerebral Aneurysm Epidemiology

The cerebral aneurysm epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of cerebral aneurysms demonstrates notable regional variation in incidence and rupture risk. According to Mohammed Faluk et al., 2024, the incidence of aneurysmal subarachnoid hemorrhage ranges from 6 to 16 per 100,000 individuals, accounting for approximately 30,000 cases annually in the United States, with peak presentation between 30 and 60 years and increasing female predominance after 50 years. As per Shigeo Yamashiro et al., 2025, unruptured intracranial aneurysms affect about 3% of the global population and 3.2% in Japan, where rupture risk is higher than in Western countries. According to Narayana Health, India reports an estimated 76,000 to 200,000 cerebral aneurysm cases annually, reflecting a significant regional burden.

Cerebral Aneurysm: Treatment Overview

The management of cerebral aneurysms depends on their size, location, rupture status, and patient-specific risk factors. Treatment options include surgical clipping, in which a metal clip is placed at the aneurysm neck to prevent blood flow, and endovascular coiling. This minimally invasive procedure induces clot formation within the aneurysm sac. Flow-diverting stents and embolization devices are also used in selected cases. For ruptured aneurysms, urgent intervention is required, along with supportive care to manage intracranial pressure and prevent complications such as vasospasm and rebleeding.

Key Questions Answered

• What are the key findings of cerebral aneurysm epidemiology in the 8 major markets?
• What will be the total number of patients with cerebral aneurysm across the 8 major markets during the forecast period?
• What was the country-wise cerebral aneurysm epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cerebral aneurysm patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of cerebral aneurysm during the forecast period of 2026-2035?
• What are the currently available treatments for cerebral aneurysm?
• What are the disease risks, signs, symptoms, and unmet needs of cerebral aneurysm?

Scope of the Cerebral Aneurysm Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of cerebral aneurysm based on several factors.
• Cerebral Aneurysm Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The cerebral aneurysm report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.